Most Recent
Publishers hit with defamation suits over ‘Medicare scandal’ reports
Defamation 2023-10-17 3:26 pm By Sam Matthews

Two cosmetic surgeons have filed defamation suits seeking aggravated damages over coverage by the ABC and Fairfax that allegedly painted them as “outlaw surgeons” who mutilated a patient and exploited the Medicare system.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Monash Health wins appeal over ‘sham’ restructure of library services
Appeals 2023-10-17 10:03 pm By Cindy Cameronne

Monash Health has won its challenge to a decision finding it wrongfully dismissed a librarian in a ‘sham’ redundancy.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Class action investigation underway into Cipro antibiotic
Class Actions 2023-10-11 3:30 pm By Sam Matthews

An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

ACL offers sell-off to win approval for $1.5B Healius merger
Corporate 2023-10-03 1:17 pm By Sam Matthews

Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Allegations of evidence burning fly in Monash IVF class action
Class Actions 2023-09-28 11:21 pm By Sam Matthews

Monash IVF is gearing up for a legal privilege fight as it faces new claims about the team of senior doctors and directors working on a novel testing technique at the heart of a class action, including claims that one doctor “burnt paper evidence” from a trial of the technology.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Judge dismisses Sanofi’s concerns about Amgen hot tub gang-up
Intellectual Property 2023-09-28 11:31 am By Sam Matthews

Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns about Amgen having a majority of experts giving concurrent evidence. In an application filed at the beginning of the month, the French pharmaceutical company sought to bar Amgen from relying…

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

A judge’s guide to winning the class action settlement administration gig
Class Actions 2023-09-26 11:30 pm By Cindy Cameronne

A former top judge appointed to decide the first-ever contest to administer a class action settlement has set out his criteria for making the choice, and has warned that giving the firm running a case a monopoly right to dole out the proceeds could lead to higher costs for group members and poorer settlement outcomes.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Junior doctors to face another hurdle after class action victory
Class Actions 2023-09-25 10:53 pm By Cat Fredenburgh

The first healthcare provider to be found liable in one of several underpayments class actions by junior doctors is challenging a ruling that found permission to work overtime hours did not have to be expressly given.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Cipla sues to invalidate Bristol-Myers’ patents for DVT drug
Intellectual Property 2023-09-20 11:03 pm By Cat Fredenburgh

Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Plastic surgeon Daniel Lanzer faces new suit over alleged botched liposuction
Healthcare 2023-09-20 11:45 pm By Cindy Cameronne

Sydney-based plastic surgeon Daniel Lanzer, who is facing a class action by 1,000 former patients, has been hit with a new lawsuit alleging he performed a negligent liposuction and fat transfer procedure, which left a woman with disfigurement, necrosis and nerve damage.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.